In EC, it has been shown in in vitro studies that leptin inhibits the apoptosis of endometrial carcinoma cells through activation of the nuclear factor κB-inducing kinase/IκB kinase pathway (49) and stimulates endometrial carcinoma cell proliferation via enhancing P450arom expression and estradiol synthesis (56). The gene discussed is LEP; the disease is endometrial carcinoma.